ICL is benefiting from stronger potash, bromine, and specialty product momentum, but elevated leverage and weak historical earnings keep the stock in Hold territory.
ICL Group Ltd. (ICL) is a Hold for moderate-risk investors seeking exposure to potash, phosphate, bromine, specialty fertilizers, and food ingredients without relying on a single commodity cycle. The company delivered strong operating momentum in 2026, including Q3 sales of $1.91B, adjusted EBITDA of $402M, and adjusted EPS of $0.10. However, the investment case remains balanced by elevated leverage, weak 2025 earnings, high sulfur costs, Brazil exposure, and a forward valuation that is demanding relative to the company's modest reported growth.
The strongest part of the story is the combination of mineral assets and higher-value applications. ICL reported Q2 2026 sales growth of 17% and adjusted EBITDA growth of 28%, while Industrial Products, Potash, and Phosphate Solutions all contributed. Management also reiterated 2026 adjusted EBITDA guidance of $1.5B to $1.7B and launched the Elevate program, which targets more than $150M of annual EBITDA improvement by the end of 2027 and more than $350M by the end of 2028.
That opportunity is offset by the quality of recent earnings. Annual revenue fell from $10.02B in 2022 to $7.15B in 2025, while net income declined from $2.16B to $226M over the same period. ICL is improving from that low base, but the reported 2025 operating margin was 9.8% and net margin was 3.2%. The stock therefore needs continued execution on pricing, cost control, and specialty-product growth before it earns a stronger rating.
ICL is a global specialty minerals and chemicals company headquartered in Tel Aviv-Yafo, Israel. Founded in 1968, the company employs 12,165 people and trades on the NYSE under ICL. Its portfolio covers agriculture, food, pharmaceuticals, electronics, energy storage, oil and gas, construction, water treatment, automotive, and healthcare.
The current reporting structure contains Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. Management plans to introduce Nutrition Solutions, Industrial Products, Growing Solutions, and Essential Minerals beginning in the first quarter of 2027. The reorganization will place food and health products together, combine upstream potash and phosphate fertilizers under Essential Minerals, and align industrial products with electronics, energy, and construction applications.
ICL's economic profile is unusual within agricultural inputs. It combines resource ownership in potash, phosphate, bromine, salt, and magnesium with specialty formulations and customer-specific chemistry. That combination gives the company exposure to commodity pricing while also creating higher-value niches where product performance, formulation expertise, and supply reliability matter.
Industrial Products generated Q2 2026 sales of $414M, up 30% year over year, and EBITDA of $130M, up 88%. Bromine prices and improved electronics demand supported flame retardants, while specialty minerals benefited from stronger magnesia demand in food and pharmaceutical applications. Clear brine fluids remained solid, although timing reduced sales slightly.
Potash produced Q2 sales of $468M, up 22%, and EBITDA of $154M, up 34%. The average potash price reached $376 per ton, up 13% year over year and 4% sequentially. Production reached 1.06 million metric tons, while sales volume reached 1.08 million metric tons. Process optimization and cost reduction supported the improvement.
Phosphate Solutions delivered Q2 sales of $722M, up 13%, but EBITDA increased only 1% to $136M. Higher phosphate prices offset part of the increase in sulfur and other raw material costs. Food phosphates gained volume from existing and new customers in dairy, meat, and seafood, especially in China and India. Industrial phosphates also benefited from demand linked to electric vehicle production capacity in China.
Growing Solutions reported Q2 sales of $605M, up 12%, while EBITDA fell to $50M from $56M. Higher nitrogen and sulfur costs, geopolitical tensions, and supply chain volatility outweighed sales growth. Brazil accounts for one-third of the business and remained weak because of affordability and financing pressure, while Europe improved through tighter product and country focus.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Potash remains ICL's clearest flagship volume product. The company describes itself as one of the most competitive global potash suppliers and holds approximately 7% global market share. Its Dead Sea operations, production in Spain, and customer access through regional logistics provide a resource-backed position in a market where mine quality, transport cost, and reliability influence margins.
The Q2 2026 potash result shows the operating leverage in that asset base. A 13% year-over-year price increase and an 11% production increase supported a 34% EBITDA increase. Management described the market as stable, with demand across granular markets in Brazil, the United States, and Europe and standard-grade demand in India and China.
Bromine is the more powerful near-term earnings swing factor. Spot bromine prices peaked above $6,000 per ton in April 2026, moderated in May and June, and stood around $4,500 during the Q2 discussion. That pricing helped Industrial Products achieve its best quarterly performance since the end of 2022. The benefit is attractive, but commodity-linked pricing makes this earnings stream less predictable than specialty food or crop nutrition products.
ICL's innovation strategy centers on Specialty Crop Nutrition and Specialty Food Solutions. Specialty Crop Nutrition sales grew from approximately $1.0B in 2020 to $2.0B in 2025, while EBITDA increased from approximately $60M to more than $200M. That record gives the growth program a concrete operating base rather than a purely aspirational narrative.
Specialty Food Solutions adds a second growth avenue. ICL leads a phosphate food specialties market valued by management at $1.5B and is expanding into functional food ingredients. Management cites an addressable market of approximately $35B with an expected average five-year growth rate of approximately 6%, alongside an ambition to reach $1.5B of revenue by 2029.
ICL is also using AI in product development, operational efficiency, and decision-making. The company is developing a high-protein beverage prototype tied to the GLP-1 category and is positioning Industrial Products toward advanced electronics, semiconductors, data centers, and next-generation computing. These initiatives improve the growth profile, although the current financial statements still reflect a business with substantial commodity exposure.
ICL operates more than 40 production sites across a complex global logistics network. Its key operational advantages include access to Dead Sea minerals, phosphate resources in Israel and China, potash resources in Israel and Spain, and production and customer networks across North America, Europe, Asia, and South America.
The supply chain also carries material risk. Sulfur prices rose 72% sequentially and more than 210% year over year in Q2 2026, while ocean freight prices rose 45% on average because of Middle East disruptions. ICL secured sulfur quantities for Q3 and the beginning of Q4, but management expects consumption costs to remain higher than in the first half.
Management is responding through pricing, inventory management, hedging, production allocation, and the Elevate cost program. A specialty fertilizer facility opened in Maharashtra, India, in March 2026, adding regional production capacity in one of ICL's stated growth markets. The operating model is becoming more local and specialized, but the company remains exposed to freight, currencies, sulfur, and security conditions.
The fertilizer market provides a large base for ICL. Mordor Intelligence estimates the global fertilizer market at $229.6B in 2026, with a projected increase to $294.0B by 2032. Grand View Research estimates the specialty fertilizer market at $42.2B in 2026, rising to $62.2B by 2033 at a 5.7% compound annual growth rate.
Controlled-release fertilizers are a smaller but faster-growing niche. Fortune Business Insights estimates that market at $1.75B in 2026 and $3.46B by 2034, representing an 8.9% compound annual growth rate. ICL's presence in controlled-release, water-soluble, organic, and specialty fertilizers gives it access to these higher-value segments rather than exposure only to bulk nutrients.
Demand remains tied to crop economics. Grain prices improved during Q2, but ICL reported that farmer affordability remained a concern. U.S. inflation-adjusted net farm income is forecast to decline 2.6% in 2026, while Brazil faces real interest rates above 9% and constrained crop financing. Those conditions favor essential commodity fertilizer volumes over premium specialty products in stressed regions.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
ICL serves a diverse customer base. Agricultural customers purchase potash, phosphate fertilizers, controlled-release products, water-soluble fertilizers, secondary nutrients, biostimulants, soil conditioners, seed treatments, and adjuvants. Food and health customers use phosphate ingredients in dairy, meat, seafood, beverages, nutrition, and pharmaceutical applications.
Industrial customers include electronics manufacturers, energy storage companies, oil and gas operators, construction businesses, paint and coating producers, automotive companies, power plants, and water treatment operators. Bromine-based flame retardants benefited from improved electronics demand in Q2, while clear brine fluids remained tied to well-completion activity.
Geographic diversity is a central part of the customer strategy. Q2 food phosphate growth included China and India, Europe improved in Growing Solutions, and potash demand covered Brazil, the United States, Europe, India, and China. Brazil remains an important specialty crop nutrition market, but its one-third share of Growing Solutions also creates concentration in a weak financing environment.
In potash, ICL competes with Nutrien, Mosaic, K+S, Uralkali, Belaruskali, SQM, EuroChem, Arab Potash, and producers in Laos. In phosphate fertilizers and specialties, relevant competitors include Mosaic, Nutrien, Prayon, Innophos, Emaphos, and Chinese producers. Specialty crop nutrition competition includes Yara, K+S, SQM, Tessenderlo, Compass Minerals, Haifa, Arab Potash, and Van Iperen.
ICL's advantage is its mix. Pure commodity producers have greater sensitivity to fertilizer prices, while pure specialty companies lack the same mineral resource base. ICL combines the Dead Sea, phosphate resources, bromine chemistry, specialty formulations, and global distribution. Its approximately 7% potash market share gives it scale, while its stated leadership in controlled-release fertilizers and specialty plant nutrition gives it differentiation.
The competitive weakness is margin consistency. Phosphate Solutions grew sales 13% in Q2 but EBITDA only 1% because raw material inflation consumed much of the pricing benefit. Growing Solutions also increased sales 12% while EBITDA declined. The portfolio has strategic breadth, but breadth alone does not guarantee superior returns.
ICL is directly exposed to the Middle East security environment because Israel contains important production and resource assets. The Q2 results reflected higher ocean freight, exchange-rate pressure, and raw material costs linked to regional disruption. The company also faces long-term regulatory exposure around the Dead Sea concession, including the next concession process in 2030.
Sulfur is the most immediate macro pressure on phosphate margins. ICL secured quantities for Q3 and early Q4, but its management team expects higher consumption costs. A diversified portfolio helps the company allocate sulfur across customers and end markets, although it does not remove the cost inflation.
Agricultural affordability is the other major macro issue. Grain prices improved, yet U.S. farm income and Brazilian financing conditions remain difficult. This creates a two-speed market: bulk potash demand remains stable, while specialty fertilizer demand in Brazil is weaker. The contrast explains why ICL's commodity segments performed better than Growing Solutions in Q2.
Net debt remains elevated after a period of weaker earnings, leaving ICL with less flexibility even as operating momentum improves.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →2025 revenue fell to $7.15B and net income dropped to $226M, though Q2 2026 sales and EBITDA both rebounded sharply.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Management still guides to $1.5B-$1.7B of 2026 adjusted EBITDA and expects Elevate to add more than $150M annually by 2027.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →The stock’s C+ valuation grade reflects a forward multiple that looks rich relative to modest reported growth and uneven margins.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →At $5.74, ICL sits near our fair value estimate, with upside tied to execution on potash, bromine, and specialty product growth.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →ICL is a recovering cyclical materials company with a credible specialty-growth layer. Its most important assets are the Dead Sea mineral platform, approximately 7% global potash share, bromine chemistry, specialty food phosphates, and a growing crop nutrition portfolio. Q2 and Q3 2026 results confirm that pricing and operating execution have improved from the 2025 trough.
The investment case becomes stronger if Elevate delivers more than $150M of annual EBITDA improvement by the end of 2027, specialty crop nutrition continues its five-year expansion, and sulfur and freight costs moderate. The case weakens if Brazil remains soft, phosphate margins compress, debt rises faster than EBITDA, or commodity prices reverse.
For a medium-term investor, ICL is better viewed as a disciplined Hold than as an aggressive growth purchase. The company has enough asset quality and operating momentum to remain investable, but the current earnings base needs to broaden and cash generation needs to improve before the stock earns a Buy rating.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →Not ready to subscribe? ·
Cancel anytime
ICL Group Ltd (ICL) slips after a Q3 miss, but the deeper story is mixed. Margins held, EBITDA rose, and guidance stayed intact, yet revenue fell short and soft agriculture demand, higher costs, and cautious analyst sentiment kept pressure on the stock.
ICL Group Ltd (ICL) slips 1.7% after reporting earnings misses, as investors react to weaker-than-expected results and reassess the stock's near-term outlook.
Riskified Ltd. (RSKD) spiked after a broad third-quarter earnings beat, but the deeper story is stronger revenue scale, improving operating leverage, record free cash flow, and raised full-year guidance. This analysis goes beyond the headline to examine margin trends, category growth, and what the latest quarter means for the stock.